State-of-the-art of nuclear medicine and molecular imaging in China: after the first 66 years (1956–2022)

Detalles Bibliográficos
Autores principales: Lan, Xiaoli, Huo, Li, Li, Shuren, Wang, Jing, Cai, Weibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167647/
https://www.ncbi.nlm.nih.gov/pubmed/35665836
http://dx.doi.org/10.1007/s00259-022-05856-z
_version_ 1784720844138741760
author Lan, Xiaoli
Huo, Li
Li, Shuren
Wang, Jing
Cai, Weibo
author_facet Lan, Xiaoli
Huo, Li
Li, Shuren
Wang, Jing
Cai, Weibo
author_sort Lan, Xiaoli
collection PubMed
description
format Online
Article
Text
id pubmed-9167647
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-91676472022-06-07 State-of-the-art of nuclear medicine and molecular imaging in China: after the first 66 years (1956–2022) Lan, Xiaoli Huo, Li Li, Shuren Wang, Jing Cai, Weibo Eur J Nucl Med Mol Imaging Editorial Springer Berlin Heidelberg 2022-06-06 2022 /pmc/articles/PMC9167647/ /pubmed/35665836 http://dx.doi.org/10.1007/s00259-022-05856-z Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Editorial
Lan, Xiaoli
Huo, Li
Li, Shuren
Wang, Jing
Cai, Weibo
State-of-the-art of nuclear medicine and molecular imaging in China: after the first 66 years (1956–2022)
title State-of-the-art of nuclear medicine and molecular imaging in China: after the first 66 years (1956–2022)
title_full State-of-the-art of nuclear medicine and molecular imaging in China: after the first 66 years (1956–2022)
title_fullStr State-of-the-art of nuclear medicine and molecular imaging in China: after the first 66 years (1956–2022)
title_full_unstemmed State-of-the-art of nuclear medicine and molecular imaging in China: after the first 66 years (1956–2022)
title_short State-of-the-art of nuclear medicine and molecular imaging in China: after the first 66 years (1956–2022)
title_sort state-of-the-art of nuclear medicine and molecular imaging in china: after the first 66 years (1956–2022)
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167647/
https://www.ncbi.nlm.nih.gov/pubmed/35665836
http://dx.doi.org/10.1007/s00259-022-05856-z
work_keys_str_mv AT lanxiaoli stateoftheartofnuclearmedicineandmolecularimaginginchinaafterthefirst66years19562022
AT huoli stateoftheartofnuclearmedicineandmolecularimaginginchinaafterthefirst66years19562022
AT lishuren stateoftheartofnuclearmedicineandmolecularimaginginchinaafterthefirst66years19562022
AT wangjing stateoftheartofnuclearmedicineandmolecularimaginginchinaafterthefirst66years19562022
AT caiweibo stateoftheartofnuclearmedicineandmolecularimaginginchinaafterthefirst66years19562022

Ejemplares similares